# Nuvation Bio Inc. — Form D

Nuvation Bio Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-20. The offering totals $275.3M, of which $275.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-10-20
- Form: D
- Accession: 0001739074-20-000013
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $275.3M
- Amount sold: $275.3M
- Investors: 57
- Date of first sale: 2019-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-378335

## Issuer

- Name: Nuvation Bio Inc.
- CIK: 0001829093
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1500 BROADWAY, NEW YORK, NY, 10036
- Phone: 650-245-3818

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Robert Bazemore | Director | New York, NY |
| Kim Blickenstaff | Director | New York, NY |
| Michelle Doig | Director | Cambridge, MA |
| Kathryn E Falberg | Director | New York, NY |
| David Hung, M.D. | Director | New York, NY |
| Claudio Nessi | Director | Philadelphia, PA |
| W. Anthony Vernon | Director | New York, NY |
| Daniel Anthony Welch | Director | New York, NY |
| David Hung, M.D. | Executive Officer | New York, NY |

## More

- [CIK 1829093 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1829093&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001739074-20-000013.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.